Benchmark Holdings plc

("Benchmark" or the "Company")

Notice of Q2 and Interim Results

Webcast for analysts and institutional investors

Equity Development webcast for retail investors

Benchmark Holdings plc (AIM: BMK), the aquaculture health, advanced nutrition, and genetics business, will announce its Q2 and Interim results, for the three and six month periods ended 31 March 2022, on Wednesday 18 May 2022. 

Webcast for analysts and institutional investors at 9am UK time

Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial Officer will host a webcast for analysts and institutional investors on that day at 9am UK time. Details will be sent out separately. If you have any questions, please contact Charlie Protheroe at MHP Communications on 020 3128 8990 or email [email protected].

Equity Development investor presentation for retail investors at 2pm UK time

Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial Officer will host a separate webcast for retail investors and wealth managers at 2pm UK time. The webcast is free and open to all existing and potential shareholders. Questions can be submitted during the presentation to be addressed at the end.

To register for the event, please click here.

A recording of the event will be available afterwards here.

For further information please contact Hannah Crowe / Matt Evans: 020 7065 2692.

   Enquiries

About Benchmark

Benchmark's mission is to enable aquaculture producers to improve their sustainability and profitability.

We bring together biology and technology, to develop innovative products which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out.

Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (Artemia), diets and probiotics and sea lice treatments. Find out more at www.benchmarkplc.com